Английская Википедия:GSK-4112

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

GSK-4112 is an experimental drug that was developed by GlaxoSmithKline as an agonist of Rev-ErbAα.[1] It is used for studying regulation of the circadian rhythm and its influence on diverse processes such as adipogenesis,[2][3] regulation of bone density,[4] and inflammation.[5][6][7][8]

See also

References

Шаблон:Reflist

Шаблон:Pharm-stub